Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Phone:617-632-3685 (Monday-Friday 8a-5p; for non-urgent items only. For medical emergencies, please have Dr. Castillo paged through the pager operator at 617-632-3352) I am the nurse practitioner (NP) at the Bing Center for Waldenstrom Macroglobulinemia (BCWM). I joined the team in September 2019, and I am very proud to work with this driven and caring group of colleagues (and patients). As the BCWM team NP, I personally see patients in the BCWM clinic and I work closely with our physician team in delivering care to our patient population. I enjoy working with individuals across the spectrum of their disease (spanning from watchful waiting to active treatment), and offering my skills in listening, health assessment, patient education, problem solving, and symptom management. I am a sub-investigator on BCWM-led clinical trials which explore use of investigational treatment regimens for WM. I contribute to the overall conduct of these clinical trials, especially in regards to direct care management and evaluation of trial participants. I have been a sub-investigator on studies exploring treatments including zanubrutinib (subsequently FDA approved for WM), venetoclax (subsequently recommended for WM use per NCCN guidelines), pirtobrutinib, CLR-131, loncastuximab tesirine, novel combination therapies, ulocuplumab, umbralisib, mavorixafor, and more to come. Outside of clinical trials, I am also involved in the care of patients treated with standard of care regimens such as BTK inhibitors, proteasome inhibitors, monoclonal antibodies, BCL2 inhibitors, and chemotherapies. I have co-authored peer-reviewed publications, and contributed to work presented by fellow BCWM team colleagues and collaborators at meetings…
Read more..